This message was sent to ##Email##
|
|
|
|
| |
The International Transplant Nurses Society (ITNS) 2020 Annual Meeting will be held online. Your registration fee includes access to all educational sessions (live and recorded), e-posters, and exhibits. Earn up to 30 hours of CE/CEPTC. Register by September 30 and save $100. Sign up today.
American Journal of Transplantation
There are limited data describing COVID‐19 in lung transplant recipients. Researchers performed a single center, retrospective case series study of lung transplant patients followed by the Columbia Lung Transplant program who tested positive for SARS‐CoV‐2 between March 19‐May 19, 2020. 32 lung transplant patients developed mild, moderate, or severe COVID‐19.
READ MORE
TIME Magazine
The man on the Dec. 15, 1967 cover of TIME would have been easy to mistake for an actor, ambassador or politician. But the chiseled face instead belonged to Dr. Christiaan Barnard, a 45-year-old heart surgeon from a little-known hospital in Cape Town. He was enjoying the international spotlight after pulling off a once-unthinkable feat: transplanting a human heart.
READ MORE
|
Promoted by
|
|
|
|
 |
The Conversation
On Dec. 9, 2008, 45-year-old Connie Culp became the first person in the United States, and only the fourth in the world, to receive a face transplant. Connie’s transplant took a team at the Cleveland Clinic in Ohio more than 22 hours to perform and allowed her to eat solid food again, to smell, and to breathe independently. Four years earlier, Connie had been shot in the face by her husband, who was subsequently imprisoned for seven years for aggravated attempted murder. Sadly, Connie died on July 29, 2020, of an as yet unspecified infection.
Although Connie’s story, of physical abuse at the hands of a partner, is regrettably common, her surgery was exceptionally rare. Our ongoing research shows that there have been 47 face transplants worldwide, if we count two re-transplants, including that of another American woman called Carmen Tarleton.
READ MORE
Healio
For patients with advanced chronic kidney disease, differences in health-related quality of life — including depressive symptoms and physical function — were associated with variations in time to wait-list for kidney transplantation.
This finding led Meera Nair Harhay, MD, MSCE, associate professor of medicine at Drexel University College of Medicine, to suggest that assessing HRQoL in late-stage CKD might provide insight into the motivations and barriers to kidney transplantation, while also helping to guide patient-physician discussions on renal replacement therapy options.
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients.
See the Video
|
|
Clinical Oncology News
Liver transplant patients who receive checkpoint inhibitors for the treatment of cancer may be at increased risk for injury or loss of the donor organ, new research shows.
In patients who have undergone a liver transplant, a systematic review of the literature suggests there is a risk for graft injury and graft loss in liver transplant recipients who are treated with immune checkpoint inhibitors.
READ MORE
Nephrology Times
Patients undergoing kidney transplantation are at risk for new-onset diabetes after transplantation. Z. Li and colleagues at the Kidney Disease Center, First Affiliated Hospital of Zhejiang University, Hangzhou, China, conducted a study designed to examine the risk factors for NODAT and to evaluate early graft function via pre-transplant oral glucose tolerance test and post-transplant blood glucose state.
The researchers reported results of the study during a poster session at the American Transplant Congress 2019. The poster was titled New-Onset Diabetes after Kidney Transplantation: Risk Factors and Early Graft Function Outcome.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Immunosuppressive medications can be a financial burden for kidney transplant patients, potentially costing as much as $10,000 to $14,000 a year. These expenses can have a negative impact on patients’ lives and may play a role in medication nonadherence, which is associated with transplant failure. Learn more about support that is available with a free 30-day trial to allow your patients to start immediately at no cost. And, for patients who are eligible with commercial insurance coverage, a $0 co-pay card offers significant savings.
Find out more
|
Clinical Transplantation
Waitlisted kidney transplant patients suffer from excess cardiovascular events. The benefits of regular cardiac investigations, potentially harmful and expensive, are unknown. Researchers investigated the effectiveness of a cardio‐renal MDT in managing high cardiovascular risk waitlisted transplant patients to prevent events and enable transplantation.
READ MORE
Cancer via MD Linx
Researchers describe their experience of treating 17 patients with immune checkpoint inhibitors for metastatic malignancies following receiving solid organ transplantation, to ultimately determine the safety as well as efficacy of these agents in transplant recipients.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
